Tiny artificial bronchus implant aims to help emphysema patients breathe

NCT ID NCT05087641

Ongoing Disease control Sponsor: Pulmair Medical, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early trial is testing a device called the Implantable Artificial Bronchus (IAB) in 20 adults with COPD or emphysema. The device is placed in the airways using a bronchoscope to relieve lung overinflation and improve airflow. The main goal is to check safety, looking for serious breathing-related complications, before moving to a larger effectiveness study.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Implantable Artificial Bronchus (IAB) device
What this could lead to: If it works, this could point toward a new device-based treatment to help COPD/emphysema patients breathe easier by reducing lung overinflation.
What could go wrong: This is a very small, early safety trial with only 20 participants. The device involves bronchoscopic implantation and carries risks like pneumonia, airway injury, or respiratory failure. Success is far from guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EMPHYSEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset pulmonary emphysema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EMPHYSEMA PULMONARY DISEASE, CHRONIC OBSTRUCTIVE

Contacts and locations

Locations

Hospital de Clinicas de Porto Alegre

Porto Alegre, CEP 90035-003, Brazil
Thoraxklinik, University of Heidelberg

Heidelberg, D-69126, Germany
University Medical Center Groningen

Groningen, 9713 GZ, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.